Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Liver Failure × halofantrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Primary Graft Dysfunction 1 Liver Neoplasms 1 Liver Failure, Acute 1 Liver Failure 1 Liver Diseases 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1

Interventions

maltodextrin 1 halofantrine 1 N-monoacetylcystine 1 Everolimus 1 Amino Acids 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01394497 2013-02-18

Use of N-Acetylcysteine During Liver Procurement

Azienda Ospedaliera di Padova

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Liver Failure, Liver Failure, Acute, Primary Graft Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡